Fourth boy dies in Astellas-Audentes gene therapy trial, raising fresh fears for the field
A fourth boy has died in the Astellas-Audentes gene therapy trial for a rare muscle-wasting disease, the company announced Tuesday morning …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
